Track the Cardinal Health, Inc share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 19 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Mary Scherer. Every trade is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,979 of 29,051 companies
18.5
score / 100
Value
24
Quality
13
FCF yld-3.8%
Earn yld-4.8%
EV/EBITDA·
ROE-40%
Gross mgn3.8%
Net mgn-0.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
11,650 shares@ US$235.7209100.0% of flowCommonSEC144:0001628280-26-057724
7 of 7 declarations
About Cardinal Health, Inc
Cardinal Health, Inc is an American company that specializes in the distribution of pharmaceuticals and medical devices. It also provides supply chain management services to healthcare institutions.